Article info

Download PDFPDF

Original research
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease

Authors

  • Leonie Maria Frommert Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Amanthi Nadira Arumahandi de Silva Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Jan Zernicke Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Veronika Scholz Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Tanja Braun Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Lara Maria Jeworowski Institute of Virology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, GermanyGerman Centre for Infection Research (DZIF), Associated Partner Site, Berlin, Germany PubMed articlesGoogle scholar articles
  • Tatjana Schwarz Institute of Virology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, GermanyGerman Centre for Infection Research (DZIF), Associated Partner Site, Berlin, Germany PubMed articlesGoogle scholar articles
  • Pinkus Tober-Lau Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Alexander ten Hagen Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Elisa Habermann Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Florian Kurth Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Leif Erik Sander Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Victor Max Corman Institute of Virology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, GermanyGerman Centre for Infection Research (DZIF), Associated Partner Site, Berlin, GermanyLabor Berlin, Charité - Vivantes GmbH, Berlin, Germany PubMed articlesGoogle scholar articles
  • Gerd-Rüdiger Burmester Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Robert Biesen Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Fredrik N. Albach Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Jens Klotsche Epidemiology Unit, German Rheumatism Research Center Berlin – a Leibniz Institute (DRFZ), Berlin, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Fredrik N. Albach; fredrik.albach{at}charite.de
View Full Text

Citation

Frommert LM, Arumahandi de Silva AN, Zernicke J, et al
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease

Publication history

  • Received August 8, 2022
  • Accepted November 1, 2022
  • First published December 6, 2022.
Online issue publication 
December 06, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.